Sornaraja Thasma

Sornaraja Thasma serves as Director of Business and Quality Assurance, leading the integrated teams within ProRelixResearch committed to delivering exceptional clinical development services and flexible support to Pharmaceutical/Biotech and medical device clients.

Dr.Thasma has over 2 decade of clinical research experience both within the pharmaceutical and CRO sectors. During this time he has worked at all levels and across operational and commercial functions within the industry. Dr.Thasma has held roles including Global Head of the Clinical Research Division at ProRelixResearch. Within each role he has made significant contributions to the successful growth and development of the company through his strategic business plans.

Prior to joining ProRelixResearch, He was heading the Business Development and Operation in the UK based Preclinical CRO, during this time his focus changed from purely operational activities to include strategic and corporate development activities in preclinical invitro services for Oncology, Respiratory, Immunology Therapeutic Areas.

Before this time Dr.Thasma worked in the Clinical Development, Project, Operations and Program management in the UK / EU based Biotechs/ Pharma companies and Various NHS-UK hospitals. During these position, he had worked in the discovery and development of novel drugs for CNS/Hearing Disorders/ Immuno-Modulator Therapy and various Immunology and Respiratory conditions. He coordinated both clinical and preclinical efforts in the areas of Oncology, Cognitive impairment and Auditory Disorders, directed project teams responsible for early drug development phase (Phase I) to the end of Phase III/IV.

Dr.Thasma holds Masters in Clinical Research from London City University, an MSc in Information Management from Alagappa University and a Bachelors in Bio-Medical Science from Dr. M.G.R University. He has authored numerous academic publications and written various articles on clinical research topics.